Skip to main content

Advertisement

SpringerLink
Log in

Striking Pathology Gold: A Singular Experience with Daily Reverberations: Sinonasal Hemangiopericytoma (Glomangiopericytoma) and Oncogenic Osteomalacia

  • North American Society of Head and Neck Pathology Companion Meeting, March 18, 2012, Vancouver, British Columbia
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

Sinonasal hemangiopericytoma-like tumors(SNHPC)(glomangiopericytomas)were originally conceived as histologically similar to, but biologically distinct from, their soft tissue counterparts. Re-evaluation of “hemangiopericytiomas” has determined that SNHPC (glomangiopericytomas) represent bona-fide pericyte-derived tumors, whereas most soft tissue neoplasms previously designated as hemangiopericytomas represent cellular variants of solitary fibrous tumors or other lesions with a hemangiopericytomalike growth pattern. We present an interesting case of a woman with SNHPC (glomangiopericytomas) causing oncogenic osteomalacia, and discuss the recent advances in our understanding of phosphaturic mesenchymal tumors. This particular case is an example of “Striking Pathology Gold”—a situation where the pathologist actively guides the diagnostic process, and witnesses its repercussions. “Striking Pathology Gold” may be a rare event in one’s career. However it serves to remind us of our place in the world as physicians. Working behind the scenes, we quietly change the course of countless individual destinies for the better.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  1. Stout AP, Murray MR. Hemangiopericytoma: a vascular tumor featuring Zimmermann’s pericytes. Ann Surg. 1942;116:26–33.

    Article  PubMed  CAS  Google Scholar 

  2. Armulik A, Genové G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21:193–215.

    Article  PubMed  CAS  Google Scholar 

  3. Compagno J, Hyams VJ. Hemangiopericytoma-like intranasal tumors. A clinicopathologic study of 23 cases. Am J Clin Pathol. 1976;66:672–83.

    PubMed  CAS  Google Scholar 

  4. Fletcher CD. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology. 2006;48:3–12.

    Article  PubMed  CAS  Google Scholar 

  5. Thompson LD, Miettinen M, Wenig BM. Sinonasal-type hemangiopericytoma: a clinicopathologic and immunophenotypic analysis of 104 cases showing perivascular myoid differentiation. Am J Surg Pathol. 2003;27:737–49.

    Article  PubMed  Google Scholar 

  6. Dandekar M, McHugh JB. Sinonasal glomangiopericytoma: case report with emphasis on the differential diagnosis. Arch Pathol Lab Med. 2010;134:1444–9.

    PubMed  Google Scholar 

  7. Wilson T, Hellquist HB, Ray S, Pickles J. Intranasal myopericytoma. A tumour with perivascular myoid differentiation: the changing nomenclature for haemangiopericytoma. J Laryngol Otol. 2007;121:786–9.

    Article  PubMed  CAS  Google Scholar 

  8. Kuo FY, Lin HC, Eng HL, Huang CC. Sinonasal hemangiopericytoma-like tumor with true pericytic myoid differentiation: a clinicopathologic and immunohistochemical study of five cases. Head Neck. 2005;27:124–9.

    Article  PubMed  Google Scholar 

  9. Tse LL, Chan JK. Sinonasal haemangiopericytoma-like tumour: a sinonasal glomus tumour or a haemangiopericytoma? Histopathology. 2002;40:510–7.

    Article  PubMed  CAS  Google Scholar 

  10. Hansen T, Katenkamp K, Katenkamp D. D2–40 staining in sinonasal-type hemangiopericytoma–further evidence of distinction from conventional hemangiopericytoma and solitary fibrous tumor. Virchows Arch. 2006;448:459–62.

    Article  PubMed  CAS  Google Scholar 

  11. Catalano PJ, Brandwein M, Shah DK, Urken ML, Lawson W, Biller HF. Sinonasal hemangiopericytomas: a clinicopathologic and immunohistochemical study of seven cases. Head Neck. 1996;18:42–53.

    Article  PubMed  CAS  Google Scholar 

  12. Weidner N, Bar RS, Weiss D, Strottmann MP. Neoplastic pathology of oncogenic osteomalacia/rickets. Cancer. 1985;55:1691–705.

    Article  PubMed  CAS  Google Scholar 

  13. Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer. 1987;59:1442–54.

    Article  PubMed  CAS  Google Scholar 

  14. Weidner N. Review and update: oncogenic osteomalacia-rickets. Ultrastruct Pathol. 1991;15:317–33.

    Article  PubMed  CAS  Google Scholar 

  15. Chong WH, Molinolo AA, Chen CC, Collins MT. Tumor-induced osteomalacia. Endocr Relat Cancer. 2011;18:53–77.

    Article  Google Scholar 

  16. Farrow EG, White KE. Tumor-induced osteomalacia. Expert Rev Endocrinol Metab. 2009;4:435–42.

    Article  PubMed  CAS  Google Scholar 

  17. Weiss D, Bar RS, Weidner N, Wener M, Lee F. Oncogenic osteomalacia: strange tumours in strange places. Postgrad Med J. 1985;61:349–55.

    Article  PubMed  CAS  Google Scholar 

  18. Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, Econs MJ, Inwards CY, Jan de Beur SM, Mentzel T, Montgomery E, Michal M, Miettinen M, Mills SE, Reith JD, OConnell JX, Rosenberg AE, Rubin BP, DE Sweet, Vinh TN, Wold LE, Wehrli BM, White KE, Zaino RJ, Weiss SW. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28:1–30.

    Article  PubMed  Google Scholar 

  19. Komínek P, Stárek I, Geierová M, Matoušek P, Zeleník K. Phosphaturic mesenchymal tumour of the sinonasal area: case report and review of the literature. Head Neck Oncol. 2011;3:16–20.

    Article  PubMed  Google Scholar 

  20. Shelekhova KV, Kazakov DV, Michal M. Sinonasal phosphaturic mesenchymal tumor (mixed connective tissue variant): report of 2 cases. Am J Surg Pathol. 2010;34:596–7.

    Article  PubMed  Google Scholar 

  21. Inokuchi G, Tanimoto H, Ishida H, Sugimoto T, Yamauchi M, Miyauchi A, Nibu K. A paranasal tumor associated with tumor-induced osteomalacia. Laryngoscope. 2006;116:1930–3.

    Article  PubMed  Google Scholar 

  22. Woo VL, Landesberg R, Imel EA, Singer SR, Folpe AL, Econs MJ, Kim T, Harik LR, Jacobs TP. Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:925–32.

    Article  PubMed  Google Scholar 

  23. Pedrazzoli M, Colletti G, Ferrari M, Rossetti G, Moneghini L, Autelitano L. Mesenchymal phosphaturic neoplasm in the maxillary sinus: a case report. Int J Oral Maxillofac Surg. 2010;39:1027–32.

    Article  PubMed  CAS  Google Scholar 

  24. Battoo AJ, Salih S, Unnikrishnan AG, Jojo A, Bahadur S, Iyer S, Kuriakose MA. Oncogenic osteomalacia from nasal cavity giant cell tumor. Head Neck. 2010 Dec 9. [Epub ahead of print] PubMed PMID: 21154616.

  25. Parshwanath HA, Kulkarni PR, Rao R, Joshi SK, Patil P. Phosphaturic mesenchymal tumor of ethmoid sinus. Indian J Pathol Microbiol. 2010;53:384–5.

    Article  PubMed  CAS  Google Scholar 

  26. David K, Revesz T, Kratimenos G, Krausz T, Crockard HA. Oncogenic osteomalacia associated with a meningeal phosphaturic mesenchymal tumor. J Neurosurg. 1996;84:288–92.

    Article  PubMed  CAS  Google Scholar 

  27. Peterson NR, Summerlin DJ, Cordes SR. Multiple phosphaturic mesenchymal tumors associated with oncogenic osteomalacia: case report and review of the literature. Ear Nose Throat J. 2010;89:11–5.

    Google Scholar 

  28. Gonzalez-Compta X, Mañós-Pujol M, Foglia-Fernandez M, Peral E, Condom E, Claveguera T, Dicenta-Sousa M. Oncogenic osteomalacia: case report and review of head and neck associated tumours. J Laryngol Otol. 1998;112:389–92.

    Article  PubMed  CAS  Google Scholar 

  29. Koriyama N, Nishimoto K, Kodama T, Nakazaki M, Kurono Y, Yoshida H, Tei C. Oncogenic osteomalacia in a case with a maxillary sinus mesenchymal tumor. Am J Med Sci. 2006;332:142–7.

    Article  PubMed  Google Scholar 

  30. Shelekhova KV, Kazakov DV, Hes O, Treska V, Michal M. Phosphaturic mesenchymal tumor (mixed connective tissue variant): a case report with spectral analysis. Virchows Arch. 2006;448:232–5.

    Article  PubMed  Google Scholar 

  31. Nuovo MA, Dorfman HD, Sun CC, Chalew SA. Tumor-induced osteomalacia and rickets. Am J Surg Pathol. 1989;13:588–99.

    Article  PubMed  CAS  Google Scholar 

  32. Ghosh S, Sinha R, Bandyopadhyay R, Malhotra M. Oncogenous osteomalacia. J Cancer Res Ther. 2009;5:210–2.

    Article  PubMed  Google Scholar 

  33. Savage CR, Zimmer LA. Oncogenic osteomalacia from pterygopalatine fossa mass. J Laryngol Otol. 2009;123:1052–4.

    Article  PubMed  CAS  Google Scholar 

  34. Wilkins GE, Granleese S, Hegele RG, Holden J, Anderson DW, Bondy GP. Oncogenic osteomalacia: evidence for a humoral phosphaturic factor. J Clin Endocrinol Metab. 1995;80:1628–34.

    Article  PubMed  CAS  Google Scholar 

  35. Ohashi K, Ohnishi T, Ishikawa T, Tani H, Uesugi K, Takagi M. Oncogenic osteomalacia presenting as bilateral stress fractures of the tibia. Skeletal Radiol. 1999;28:46–8.

    Article  PubMed  CAS  Google Scholar 

  36. Sandhu FA, Martuza RL. Craniofacial hemangiopericytoma associated with oncogenic osteomalacia: case report. J Neurooncol. 2000;46:241–7.

    Article  PubMed  CAS  Google Scholar 

  37. Fuentealba C, Pinto D, Ballesteros F, Pacheco D, Boettiger O, Soto N, Fernandez W, Gabler F, Gonzales G, Reginato AJ. Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma. J Clin Rheumatol. 2003;9:373–9.

    Article  PubMed  Google Scholar 

  38. Kurien R, Manipadam MT, Rupa V. Oncogenic osteomalacia in a patient with an ethmoid sinus tumour. J Laryngol Otol. 2010;124:799–803.

    Article  PubMed  CAS  Google Scholar 

  39. Chacko V, Joseph B. Osteomalacia associated with haemangiopericytoma. J Indian Med Assoc. 1981;76:173–5.

    PubMed  CAS  Google Scholar 

  40. Peters KB, McLendon R, Morse MA, Vredenburgh JJ. Treatment of recurrent intracranial hemangiopericytoma with SRC-related tyrosine kinase targeted therapy: a case report. Case Rep Oncols. 2010;3:93–7.

    Article  Google Scholar 

  41. Bielesz B. Emerging role of a phosphatonin in mineral homeostasis and its derangements. Eur J Clin Invest. 2006;36:34–42.

    Article  PubMed  CAS  Google Scholar 

  42. Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest. 2003;112:683–92.

    PubMed  CAS  Google Scholar 

  43. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006;444:770–4.

    Article  PubMed  CAS  Google Scholar 

  44. Perwad F, Zhang MY, Tenenhouse HS, Portale AA. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Am J Physiol Renal Physiol. 2007;293:1577–83.

    Article  Google Scholar 

  45. Gupta A, Winer K, Econs MJ, Marx SJ, Collins MT. FGF-23 is elevated by chronic hyperphosphatemia. J Clin Endocrinol Metab. 2004;89:4489–92.

    Article  PubMed  CAS  Google Scholar 

  46. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA. 2001;98:6500–5.

    Article  PubMed  CAS  Google Scholar 

  47. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J. The parathyroid is a target organ for FGF23 in rats. J Clin Invest. 2007;117:4003–8.

    PubMed  CAS  Google Scholar 

  48. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Jüppner H. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med. 2003;348:1656–63.

    Article  PubMed  CAS  Google Scholar 

  49. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab. 2002;87:4957–60.

    Article  PubMed  CAS  Google Scholar 

  50. Hu FK, Yuan F, Jiang CY, Lv DW, Mao BB, Zhang Q, Yuan ZQ, Wang Y. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature. Chin J Cancer. 2011;30:794–804.

    Article  PubMed  Google Scholar 

  51. Levy-Litan V, Hershkovitz E, Avizov L, Leventhal N, Bercovich D, Chalifa-Caspi V, Manor E, Buriakovsky S, Hadad Y, Goding J, Parvari R. Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am J Hum Genet. 2010;86:273–8.

    Article  PubMed  CAS  Google Scholar 

  52. Farrow EG, Davis SI, Ward LM, Summers LJ, Bubbear JS, Keen R, Stamp TC, Baker LR, Bonewald LF, White KE. Molecular analysis of DMP1 mutants causing autosomal recessive hypophosphatemic rickets. Bone. 2009;44:287–94.

    Article  PubMed  CAS  Google Scholar 

  53. Martin A, Liu S, David V, Li H, Karydis A, Feng JQ, Quarles LD. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling. FASEB J. 2011;25:2551–62.

    Article  PubMed  CAS  Google Scholar 

  54. De Beur SM, Finnegan RB, Vassiliadis J, Cook B, Barberio D, Estes S, Manavalan P, Petroziello J, Madden SL, Cho JY, Kumar R, Levine MA, Schiavi SC. Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J Bone Miner Res. 2002;17:1102–10.

    Article  PubMed  Google Scholar 

  55. Habra MA, Jimenez C, Huang SC, Cote GJ, Murphy WA Jr, Gagel RF, Hoff AO. Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalacia. Endocr Pract. 2008;14:1108–14.

    PubMed  Google Scholar 

  56. Cotant CL, Rao PS. Elevated fibroblast growth factor 23 in a patient with metastatic prostate cancer and hypophosphatemia. Am J Kidney Dis. 2007;50:1033–6.

    Article  PubMed  CAS  Google Scholar 

  57. Imel EA, Econs MJ. Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23. Pediatr Endocrinol Rev. 2007;4:434–9.

    PubMed  Google Scholar 

  58. Ben-Baruch D, Ziv Y, Sandbank J, Wolloch Y. Oncogenic osteomalacia induced by schwannoma in a patient with neurofibromatosis. Eur J Surg Oncol. 1994;20:57–61.

    PubMed  CAS  Google Scholar 

  59. Chadha M, Singh AP, Singh AP. Hypophosphataemic osteomalacia in neurofibromatosis. Acta Orthop Belg. 2009;75:847–50.

    PubMed  Google Scholar 

  60. Sprecher E. Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification. J Invest Dermatol. 2010;130:652–60.

    Article  PubMed  CAS  Google Scholar 

  61. Xu YY, Luo XM, Zhou SH, Zheng ZJ. CD34-positive expression in benign nasal glomus tumour: two case reports and a literature review. J Int Med Res. 2010;38:2169–77.

    PubMed  Google Scholar 

  62. Ganly I, Patel SG, Stambuk HE, Coleman M, Ghossein R, Carlson D, Edgar M, Shah JP. Solitary fibrous tumors of the head and neck: a clinicopathologic and radiologic review. Arch Otolaryngol Head Neck Surg. 2006;132:517–25.

    Article  PubMed  Google Scholar 

  63. Papadakis I, Koudounarakis E, Haniotis V, Karatzanis A, Velegrakis G. Atypical solitary fibrous tumor of the nose and maxillary sinus. Head Neck. 2011;. doi:10.1002/hed.21909.

    PubMed  Google Scholar 

  64. Nai GA, Ramalho Neto GC. Solitary fibrous tumor of the nasal cavity. Braz J Otorhinolaryngol. 2009;75:769.

    Article  PubMed  Google Scholar 

  65. Takasaki K, Watanabe T, Hayashi T, Kinoshita N, Kumagami H, Takahashi H. Solitary fibrous tumor arising from the sphenoid sinus. Case Report Med. 2009; 316042.

  66. Furze AD, Peng Y, Myers LL. Pathology case quiz 2. Solitary fibrous tumor of the nasal cavity and ethmoid sinus with intracranial extension. Arch Otolaryngol Head Neck Surg. 2008;134(334):336–7.

    Google Scholar 

  67. Corina L, Volante M, Carconi M, Contucci AM. An unusual solitary fibrous tumor after sphenoethmoidectomy. Otolaryngol Head Neck Surg. 2006;134:1063–5.

    Article  PubMed  Google Scholar 

  68. Martin H, Kay WN, Werner P. Angiomatous meningioma—a clinicopathologic study of 38 cases. Am J Surg Pathol. 2004;28:390–3.

    Article  Google Scholar 

  69. Ambrosini-Spaltro A, Eusebi V. Meningeal hemangiopericytomas and hemangiopericytoma/solitary fibrous tumors of extracranial soft tissues: a comparison. Virchows Arch. 2010;456:343–54.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Alabama at Birmingham, Birmingham, Al, UK

    Margaret Brandwein-Gensler & Gene P. Siegal

Authors
  1. Margaret Brandwein-Gensler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gene P. Siegal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Margaret Brandwein-Gensler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brandwein-Gensler, M., Siegal, G.P. Striking Pathology Gold: A Singular Experience with Daily Reverberations: Sinonasal Hemangiopericytoma (Glomangiopericytoma) and Oncogenic Osteomalacia. Head and Neck Pathol 6, 64–74 (2012). https://doi.org/10.1007/s12105-012-0337-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-012-0337-8

Keywords

Search

Navigation